Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05955508 |
| Consolidated Lead Sponsor | Regeneron Pharmaceuticals |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 40 participants (ACTUAL) |
| Registered Start Date | 2024-01-30 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Hospital Universitario Virgen de las Nieves | Granada, Spain | Open Hospital Dossier -> |
| Hospital Germans Trias i Pujol | Badalona, Spain | Open Hospital Dossier -> |
| Hospital Universitario Marques de Valdecilla | Santander, Spain | Open Hospital Dossier -> |
| Hospital Clinic de Barcelona | Barcelona, Spain | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Regeneron Pharmaceuticals across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.